Regarding "Limitations in the use of rifampicin-gelatin grafts against virulent organisms"

Journal of Vascular Surgery

Volumn 35, Issue 4, 2002, Pages 823-824

  Naylor, A Ross ^a,b  

^a Leicester Royal Infirmary ^*

^b LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GELATIN; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANTIBACTERIAL ACTIVITY; AORTA GRAFT; BLOOD VESSEL GRAFT; CONTAMINATION; ESCHERICHIA COLI; EXPERIMENTAL MODEL; GRAFT INFECTION; HUMAN; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; NOTE; PRIORITY JOURNAL; STAPHYLOCOCCUS INFECTION; VIRULENCE; ANIMAL; BLOOD VESSEL PROSTHESIS; DRUG EFFECT; INFECTION; PENICILLIN RESISTANCE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

ANIMALS; ANTIBIOTICS, ANTITUBERCULAR; BLOOD VESSEL PROSTHESIS; ESCHERICHIA COLI; GELATIN; HUMANS; METHICILLIN RESISTANCE; PROSTHESIS-RELATED INFECTIONS; RIFAMPIN; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 0036548489     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2002.121851     Document Type: Article

References (9)

1. Strachan CJL, Newsom SWB, Ashton TR. The clinical use of an antibiotic bonded graft. Eur J Vasc Surg 1991;5:627-32.
2. Torsello G, Sandmann W, Gehrt A, Jungblut RM. In-situ replacement of infected vascular prostheses with rifampicin soaked vascular grafts: early results. J Vasc Surg 1993;17;768-73.
3. Hayes P, Nasim A, Sayers RD, et al. In-situ replacement of infected aortic grafts with rifampicin bonded prostheses: the Leicester experience (1992-1998). J Vasc Surg 1999;30:92-8.
4. Young RM, Cherry KJ, Davis PM, et al. The results of in-situ prosthetic replacement for infected aortic grafts. Am J Surg 1999;178:136-40.
5. Bandyk DF, Novotney ML, Back MR, Johnson BL, Schmacht DC. Expanded application of in-situ replacement for prosthetic graft infection. J Vasc Surg 2001;34:411-20.
6. Naylor AR, Darke SG, Hayes PD. A prospective audit of complex wound and graft infections in Great Britain and Ireland: the emergence of MRSA. Eur J Vasc Endovasc Surg 2001;21:289-94.
7. Nasim A, Thompson MM, Naylor AR, Bell PRF, London NJM. The impact of MRSA on vascular surgery. Eur J Vasc Endovasc Surg 2001;22:211-4.
8. Drury JK, Ashton TR, Cunningham JD, Maini R, Pollock JG. Experimental and clinical experience with a gelatin impregnated dacron prosthesis. Ann Vasc Surg 1987;1:542-7.
9. Nevelsteen A, Lacroix H, Suy R. Autogenous reconstruction of the lower extremity deep veins: an alternative treatment of prosthetic infection after reconstructive surgery for aortoiliac disease. J Vasc Surg 1995;22:129-34.